Health Canada and FDA Joint Public Consultation on International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
- October 19, 2017
- October 19, 2017
The Food and Drug Administration (FDA) is announcing a regional public meeting entitled ‘‘Health Canada and United States Food and Drug Administration Joint Public Consultation on International Council for Harmonisation of Technical Requirements for Human Use (ICH)’’ to provide information and receive comments on the current activities of ICH as well as the upcoming meetings in Geneva, Switzerland, in November 2017. The topics to be discussed are the topics for discussion at the forthcoming ICH Assembly Meeting. The purpose of the public meeting is to solicit public input prior to the next ICH Assembly meeting and the expert working groups meetings in Geneva, Switzerland, scheduled for November 11 through 16, 2017, at which the discussion of the topics underway will continue.
October 19, 2017
9:00 a.m. to 12:00 p.m. ET
Sir Frederick G. Banting Research Centre
251 Sir Frederick Banting Driveway
Ottawa, ON K1Y 0M1, Canada
A website to access the webcast will be emailed to those who those who register for the meeting as a remote attendee.
If you wish to attend the public meeting either in-person or via webcast, please register at the following website: https://www.eventbrite.ca/e/health-canada-us-fda-consultation-on-ich-live-webcast-tickets-36514966247. Registrations may be limited, so early registration is recommended. Registration is free and will be on a first-come, first-served basis. However, the number of participants from each organization may be limited based on space limitations. Registrants will receive confirmation once they have been accepted.
For more information: please contact Amanda Roache, firstname.lastname@example.org